全文获取类型
收费全文 | 4797篇 |
免费 | 258篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 122篇 |
妇产科学 | 125篇 |
基础医学 | 711篇 |
口腔科学 | 41篇 |
临床医学 | 420篇 |
内科学 | 1283篇 |
皮肤病学 | 159篇 |
神经病学 | 449篇 |
特种医学 | 171篇 |
外科学 | 449篇 |
综合类 | 11篇 |
一般理论 | 1篇 |
预防医学 | 225篇 |
眼科学 | 63篇 |
药学 | 351篇 |
中国医学 | 7篇 |
肿瘤学 | 468篇 |
出版年
2023年 | 35篇 |
2022年 | 74篇 |
2021年 | 121篇 |
2020年 | 71篇 |
2019年 | 67篇 |
2018年 | 120篇 |
2017年 | 90篇 |
2016年 | 87篇 |
2015年 | 109篇 |
2014年 | 134篇 |
2013年 | 201篇 |
2012年 | 322篇 |
2011年 | 317篇 |
2010年 | 177篇 |
2009年 | 162篇 |
2008年 | 282篇 |
2007年 | 342篇 |
2006年 | 296篇 |
2005年 | 250篇 |
2004年 | 259篇 |
2003年 | 223篇 |
2002年 | 210篇 |
2001年 | 116篇 |
2000年 | 110篇 |
1999年 | 92篇 |
1998年 | 59篇 |
1997年 | 31篇 |
1996年 | 51篇 |
1995年 | 37篇 |
1994年 | 31篇 |
1993年 | 20篇 |
1992年 | 77篇 |
1991年 | 67篇 |
1990年 | 46篇 |
1989年 | 52篇 |
1988年 | 51篇 |
1987年 | 54篇 |
1986年 | 36篇 |
1985年 | 39篇 |
1984年 | 18篇 |
1983年 | 13篇 |
1982年 | 7篇 |
1981年 | 16篇 |
1980年 | 10篇 |
1979年 | 17篇 |
1978年 | 9篇 |
1976年 | 10篇 |
1974年 | 9篇 |
1973年 | 8篇 |
1966年 | 7篇 |
排序方式: 共有5075条查询结果,搜索用时 15 毫秒
11.
Serum DU-PAN-2 in the differential diagnosis of pancreatic cancer: influence of jaundice and liver dysfunction 总被引:1,自引:0,他引:1
C Fabris A Malesci D Basso C Bonato G Del Favero M Tacconi T Meggiato P Fogar M P Panozzo C Ferrara 《British journal of cancer》1991,63(3):451-453
The usefulness of serum DU-PAN-2 in diagnosing pancreatic cancer and in distinguishing between this cancer and other benign and malignant diseases, and to assess the role of liver dysfunction in altering the serum levels of this marker were investigated. DU-PAN-2 was measured in the sera of 31 patients with pancreatic cancer, 32 with chronic pancreatitis, 20 with benign and 21 with malignant extra-pancreatic diseases. DU-PAN-2 was found to be above 300 U ml-1 in 21/31 patients with pancreatic cancer (sensitivity 68%). Only 3/32 patients with chronic pancreatitis had abnormal values. A substantial number of patients with both benign and malignant extra-pancreatic diseases had an elevated serum DU-PAN-2 (9/20 and 15/21, respectively). Correlations were found between DU-PAN-2 and (1) total bilirubin, (2) alanine-amino-transferase and (3) alkaline phosphatase. Of the patients with high DU-PAN-2 values, jaundice was found in: 2/3 with chronic pancreatitis, 9/10 with benign and 12/14 with malignant extra-pancreatic diseases. In conclusion, the serum DU-PAN-2 test for pancreatic malignancy is not completely satisfactory, because it is not sensitive enough. While the test for chronic pancreatitis has an acceptable specificity, the assay cannot distinguish between pancreatic cancer and other extra-pancreatic diseases, mainly of the liver and biliary tract. Liver dysfunction as well as jaundice seem to considerable affect the levels of this marker, as reported elsewhere for CA 19-9. 相似文献
12.
13.
14.
Cinzia Bressi Cesare Maria Cornaggia Massimiliano Beghi Matteo Porcellana Ilaria Ida Iandoli Giordano Invernizzi 《Seizure》2007,16(5):417-423
PURPOSE: To verify the emotional components expressed by the relatives of adult patients with a diagnosis of epilepsy, and whether they are related to adjustment to the illness and the course of the illness over time. METHODS: We studied a consecutive sample of 43 outpatients suffering from epilepsy and 43 key relatives using the Camberwell Family Interview (CFI), with the expressed emotion (EE) of the relatives being rated at baseline (T0). EE refers to a construct representing some key aspects of interpersonal relationships: the relatives were assigned to the high-EE group if they scored 3 or more on the emotional over involvement (EOI) scale, or showed hostility, or made 6 or more critical comments. The patients were clinically evaluated at baseline and for 1 year of appropriate treatment by an epileptologist who was blinded to the EE ratings. They also completed STAI XI, STAI X2 and Beck's Depression Inventory at baseline. RESULTS: Twenty-six relatives (60%) were rated as showing a high degree of EE. In the 12-month follow-up study, high EE and high EOI were found to be associated with a significantly higher seizure frequency than that recorded for the patients living in low-EE households (p<0.05). The patients from households assessed as reflecting a high degree of criticism showed poor drug compliance (p<0.01), whereas those with relatives assessed as having a high degree of warmth showed better clinical and pharmacological compliance (p<0.01). High family criticism scores also correlated with higher study entry levels of depression (p<0.05) and trait and state anxiety (p<0.05) among the patients. CONCLUSIONS: The study findings highlight the impact of particular components of the family emotional climate on the clinical course and psychological adjustment of patients with epilepsy. 相似文献
15.
Jeffery J Auletta Jennifer L Devecchio James L M Ferrara Frederick P Heinzel 《Biology of blood and marrow transplantation》2004,10(12):834-847
Defects in immune reconstitution after hematopoietic stem cell transplantation confer extreme infection risk on to the transplant recipient. Perturbations in adaptive immune reconstitution have been well characterized, yet defects in reconstituted innate cellular-mediated immunity remain largely unstudied. Recovery in innate effector cells was defined by using an established murine model of autologous bone marrow transplantation. Cytokine induction after cell culture and systemic stimulation with pathogen-associated molecular patterns was also measured for control, transplant-recipient, and irradiated-only animals. Early reconstitution (7 to 14 days) of donor-derived macrophages, dendritic cells, and polymorphonuclear cells was associated with recovery in interleukin (IL)-12p70 and IL-6 production. Later reconstitution (21 days) of natural killer cells was associated with interferon (IFN)-gamma recovery. Hence, splenocyte innate cellular-mediated immunity recovered to normal levels in cellularity and IL-12p70, IFN-gamma, and IFN-alpha production by 21 days after transplantation. In contrast, levels of systemic cytokine production from transplant-recipient and irradiated-only animals were preserved despite incomplete or absent hematopoietic reconstitution. These results suggest that innate immune responses to systemic inflammatory challenges are largely intact after autologous bone marrow transplantation, whereas local innate cellular-mediated immunity within reconstituting lymphoid organs may be impaired. The disparate effects of autologous hematopoietic stem cell transplantation on host immune function may translate to differences in susceptibility to local versus systemic infectious challenges. 相似文献
16.
Sanjiv K. Patankar M.D. M.S. F.R.C.S. Dr. Andrea Ferrara M.D. Jacqueline R. Levy M.D. Sergio W. Larach M.D. Paul R. Williamson M.D. Santiago E. Perozo M.D. 《Diseases of the colon and rectum》1997,40(7):827-831
PURPOSE: Biofeedback treatment is often offered to patients in colorectal centers; however, standards of treatment are still lacking. A dedicated team approach is desirable but difficult to coordinate. We present our three-year experience of electromyographic-based biofeedback treatment offered within a multicenter, statewide organization. METHODS: Between October 1992 and October 1995, 188 patients completed a biofeedback treatment program in one of five coordinated centers within a 200-mile radius. A unified common database was established and continuously updated. A colorectal surgeon served as statewide director, and dedicated teams were established at each location. Each local team included the medical director and a certified biofeedback therapist and had access to a dietitian and a nurse data coordinator. Electromyographic-based biofeedback sessions were given weekly, and a home trainer program was established. RESULTS: A total of 116 patients with chronic constipation had a mean of eight (range, 2–14) weekly sessions. A total of 72 patients with fecal incontinence had a mean of seven (range, 2–11) weekly sessions. A total of 84 percent of the constipated and 85 percent of the incontinent patients had significant improvement with biofeedback treatment. Patient compliance and satisfaction were high. Constipated patients increased the mean number of weekly unassisted bowel movements from 0.8 to 6.5. Incontinent patients decreased the mean number of weekly gross incontinence episodes from 11.8 to 2. CONCLUSIONS: Biofeedback treatment can be extremely successful in both incontinent and constipated patients. A large geographic area can be covered with coordinated centers in which each dedicated team uses a unified treatment protocol, and a common database is established.Poster presentation at the meeting of The American Society of Colon and Rectal Surgeons, Seattle, Washington, June 9 to 14, 1996. 相似文献
17.
Pneumoperitoneum results from perforation of the gastrointestinal tract in the majority of instances and the necessity of operative treatment is implied. In patients where peritonitis is not a problem, nonoperative treatment is successful. Surgical treatment is not required for those in whom the condition results from barotrauma. The decision to enjoin or withhold operative intervention in individual cases is judgmental. 相似文献
18.
Cinzia Azzoni Tiziana D’Adda Guido Tamburrano Carlo Coscelli Ole D. Madsen Lucio Scopsi C. Bordi 《Virchows Archiv : an international journal of pathology》1998,433(6):495-504
Sixty-seven insulinomas were investigated by immunohistochemistry using site-directed antibodies against insulin, proinsulin, chromogranin A, HISL-19, and four proteins directly or indirectly involved in the proteolytic processing of proinsulin: the prohormone convertases PC2 and PC3, carboxypeptidase H (CPH) and 7B2. Results were expressed in a six-grade score according to the frequency of immunoreactive tumour cells. Insulin was expressed by all tumours, appearing in either a diffuse or a polarized pattern and being detected in more than 30% of tumour cells in all cases but three. Proinsulin was also expressed in all tumours, with more than 50% of tumour cells immunoreactive in all cases but 5. It was consistently localized in the Golgi apparatus. In about half the cases, moreover, it also showed diffuse cytoplasmic staining, usually with a very sparse distribution. Trabecular and solid insulinomas did not present specific, homogeneous patterns of insulin immunostaining. However, insulin immunoreactivity was much more abundant in trabecular than in solid neoplasms, being present in virtually all tumour cells (score 6) in 50% and 8% of cases, respectively. Virtually all insulinomas expressed PC2, PC3, CPH and 7B2, usually in 30–100% of tumour cells, with a frequency significantly related to that of insulin. However, detection of PC2 and 7B2 was slightly less frequent than that of PC3 and CPH. In consecutive sections these proteins were found to be mostly co-localized with insulin and chromogranin A but not with proinsulin. They were heavily expressed in all 10 tumours with more than 10% of cells showing cytoplasmic proinsulin immunoreactivity, indicating that the leakage of proinsulin from the Golgi compartment is not associated with faulty expression of converting enzymes and possibly reflects a saturated processing capacity. HISL-19 immunoreactivity was found in both Golgi apparatus and insulin stores, indicating that the relevant antigen is different from all other proteins investigated. These results do not support a defect in expression or localization of proinsulin-processing enzymes in most insulinomas. 相似文献
19.
Angelo Ferrara M.D. Ph.D. Melvin Schwartz M.D. Helen Page R.N. M.P.A. Morton Israel M.A. Yucel Atakent M.D. M.S. C. E. Smith Ph.D. Leon Landovitz Ph.D. 《Journal of community health》1988,13(1):3-18
In the past two decades, there has been a gradual trend to regionalization of perinatal care, categorization of hospitals and transport services for neonatal health care. The literature alludes to both beneficial and deleterious effects of neonatal transport (T) but no controls such as a matched nontransport (NT) population have been utilized to date.The major goal of this study was to evaluate the effect of neonatal transport from Level I and II high risk 2500 gm. neonates (born in NYC in one calendar year, 1979) compared to a cohort nontransported population matched for hospital of birth, weight, race, sex and risk. All transported 2500 gm. from Level I and II (n=328) were studied and a stratified random sample of the nontransported (NT) infants 2500 gm. from these same hospitals (n=2042) was used for comparison. The principle outcome variable was survival. The major conclusion of this study is that in Level I and II hospitals the transport group had a significantly increased survival in infants who were sick (Apgar <6) compared to cohorted nontransported controls. Interhospital differences in survival were noted among Level I and II but not seen in the subdivisions of (A) and (B) hospitals.Angelo Ferrara, M.D., Ph.D., is Professor, Pediatrics, NYU Medical Center, New York, N.Y.: Melvin Schwartz, M.D., was Research Professor, Environmental Medicine, NYU Medical Center, New York, N.Y.; Helen Page, R.N., M.P.A., is Quality Assurance Reviewer, Manhattan Eye, Ear, Throat Hospital, New York, N.Y.: Morton Israel, M.A., is Research Scientist, Health Resources Administration, City of N. Y., New York, N.Y.; Yucel Atakent, M.D., M.S., is Clinical Associate Professor, NYU Medical Center, New York, N.Y.; C.E. Smith, Ph.D., is President, Health Policy Analysis & Accountability Network, Inc. (HPAAN), Edgewood, New Mexico; Leon Landovitz, Ph.D., is Vice President, Management Information Systems, Healthways System Inc., Islin, N.J.Supported by NCHSR Grant #5-R018-HSO3832 相似文献
20.
Linkage of Chido and HL-A 总被引:6,自引:0,他引:6